AU3115597A - Methods and compositions for regulating t cell subsets by modulating transcription factor activity - Google Patents
Methods and compositions for regulating t cell subsets by modulating transcription factor activityInfo
- Publication number
- AU3115597A AU3115597A AU31155/97A AU3115597A AU3115597A AU 3115597 A AU3115597 A AU 3115597A AU 31155/97 A AU31155/97 A AU 31155/97A AU 3115597 A AU3115597 A AU 3115597A AU 3115597 A AU3115597 A AU 3115597A
- Authority
- AU
- Australia
- Prior art keywords
- regulating
- compositions
- methods
- transcription factor
- cell subsets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000662 T-lymphocyte subset Anatomy 0.000 title 1
- 230000010632 Transcription Factor Activity Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5406—IL-4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Environmental Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/636602 | 1996-04-23 | ||
US08/636,602 US5958671A (en) | 1996-04-23 | 1996-04-23 | Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
US08/755,584 US5858711A (en) | 1996-11-25 | 1996-11-25 | NF-AT-interacting protein NIP45 and methods of use therefor |
US08/755584 | 1996-11-25 | ||
US08/755,592 US6537810B1 (en) | 1996-04-23 | 1996-11-25 | Methods for regulating T cell subsets by modulating transcription factor activity |
US08/755592 | 1996-11-25 | ||
PCT/US1997/006708 WO1997039721A2 (en) | 1996-04-23 | 1997-04-23 | Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
Publications (2)
Publication Number | Publication Date |
---|---|
AU3115597A true AU3115597A (en) | 1997-11-12 |
AU720455B2 AU720455B2 (en) | 2000-06-01 |
Family
ID=27417596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU31155/97A Ceased AU720455B2 (en) | 1996-04-23 | 1997-04-23 | Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0891425A2 (en) |
JP (1) | JP2000510333A (en) |
KR (1) | KR20000010606A (en) |
CN (1) | CN1225682A (en) |
AU (1) | AU720455B2 (en) |
CA (1) | CA2252643A1 (en) |
NZ (1) | NZ332897A (en) |
WO (1) | WO1997039721A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9722388D0 (en) * | 1997-10-24 | 1997-12-24 | Zeneca Ltd | NIP45 human homolog |
US6274338B1 (en) | 1998-02-24 | 2001-08-14 | President And Fellows Of Harvard College | Human c-Maf compositions and methods of use thereof |
US6548734B1 (en) | 1998-05-28 | 2003-04-15 | President And Fellows Of Harvard College | Methods relating to modulation of cartilage cell growth and/or differentiation by modulation of NFATp activity |
ES2283340T3 (en) * | 1999-12-30 | 2007-11-01 | President And Fellows Of Harvard College | METHODS CONCERNING THE MODULATION OF THE ACTIVITY OF THE TH2 CELL SUBCONJUNCT BY MODULATION OF THE ACTIVITY OF XBP-1. |
CA2394831A1 (en) * | 2000-01-11 | 2001-07-19 | Maxygen, Inc. | Monocyte-derived dendritic cell subsets |
ATE340261T1 (en) * | 2000-04-25 | 2006-10-15 | Bayer Healthcare Ag | REGULATION OF A NF-AT INTERACTING PROTEIN VARIANT NIP 45 |
WO2002029403A1 (en) * | 2000-10-02 | 2002-04-11 | Mochida Pharmaceutical Co., Ltd. | Gata-3 expression inhibitor and method of screening the same |
EP2135611A1 (en) | 2001-03-01 | 2009-12-23 | Hollis-Eden Pharmaceuticals Inc. | Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy |
US20050079496A1 (en) * | 2001-08-17 | 2005-04-14 | Edgar Serfling | Methods for diagnosing and treating neoplasias using nf-at transcriptions factors |
IL147138A0 (en) | 2001-12-17 | 2002-08-14 | Yeda Res & Dev | Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation |
EP1989544B1 (en) * | 2006-03-02 | 2011-06-22 | Antitope Limited | T cell assays |
US8940479B2 (en) | 2008-01-14 | 2015-01-27 | Cornell University | Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity |
KR101146335B1 (en) * | 2009-10-12 | 2012-05-21 | 한국원자력의학원 | TRANSGENIC MOUSE EXPRESSING REPORTER PROTEIN UNDER REGULATION OF α-FETOPROTEIN ENHANCER AND PROMOTER, METHOD FOR PREPARATION THEREOF AND METHOD FOR SCREENING COMPOUNDS INDUCING INCREASE OR DECREASE OF Α-FETOPROTEIN EXPRESSION USING THE SAME |
WO2012109238A2 (en) | 2011-02-07 | 2012-08-16 | President And Fellows Of Harvard College | Methods for increasing immune responses using agents that directly bind to and activate ire-1 |
WO2013134774A1 (en) | 2012-03-09 | 2013-09-12 | Cornell University | Modulation of breast cancer growth by modulation of xbp1 activity |
WO2015019125A1 (en) * | 2013-08-05 | 2015-02-12 | Societe De Developpement Et De Recherche Industrielle | Molecular targets for the treatment of wounds, in particular chronic wounds |
DK3049521T3 (en) | 2013-09-25 | 2019-04-23 | Univ Cornell | Compounds for inducing antitumor immunity and methods thereof |
-
1997
- 1997-04-23 CN CN97195740A patent/CN1225682A/en active Pending
- 1997-04-23 WO PCT/US1997/006708 patent/WO1997039721A2/en not_active Application Discontinuation
- 1997-04-23 KR KR1019980708492A patent/KR20000010606A/en not_active Application Discontinuation
- 1997-04-23 NZ NZ332897A patent/NZ332897A/en unknown
- 1997-04-23 CA CA002252643A patent/CA2252643A1/en not_active Abandoned
- 1997-04-23 EP EP97926377A patent/EP0891425A2/en not_active Withdrawn
- 1997-04-23 JP JP09538278A patent/JP2000510333A/en not_active Ceased
- 1997-04-23 AU AU31155/97A patent/AU720455B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
NZ332897A (en) | 2000-04-28 |
JP2000510333A (en) | 2000-08-15 |
AU720455B2 (en) | 2000-06-01 |
CA2252643A1 (en) | 1997-10-30 |
WO1997039721A2 (en) | 1997-10-30 |
EP0891425A2 (en) | 1999-01-20 |
CN1225682A (en) | 1999-08-11 |
WO1997039721A3 (en) | 1998-04-09 |
KR20000010606A (en) | 2000-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3115597A (en) | Methods and compositions for regulating t cell subsets by modulating transcription factor activity | |
AU1957697A (en) | Methods and compositions for the modulation of cell proliferation and wound healing | |
EP0788165A3 (en) | Storage cell arrangement and method for making the same | |
AU4655296A (en) | Compositions and methods for treating tumor cells | |
AU5969296A (en) | Chemically defined medium for human mesenchymal stem cells | |
AU4317097A (en) | Wideband code-division-multiple access system and method | |
AU3154295A (en) | Method for preserving cells, and uses of said method | |
AU5377598A (en) | Composition and method for preserving progenitor cells | |
AU9248398A (en) | Compounds and methods for regulating cell adhesion | |
AU7260398A (en) | Method and composition for modulating amyloidosis | |
AU6714396A (en) | Methods and compositions for treating cell proliferative disorders | |
AU2353997A (en) | Sealant composition, cell and battery cover, and cell and battery prepared therewith | |
AU3811597A (en) | Methods and devices for controlling the reaction by adjusting the oxidant consumption rate | |
AU1555297A (en) | Antigenic modulation of cells | |
AU2608497A (en) | Novel neuronal cell growth factor | |
HUP0003012A3 (en) | Composition and method for regulating cell proliferation and cell death | |
AUPO229696A0 (en) | Analytic cell | |
AU2980497A (en) | Recording apparatus, reproducing apparatus and conversion apparatus | |
AU2993397A (en) | Compositions and methods for modulating type i interleukin-1 receptor expression | |
AU4091897A (en) | Solid state voltage regulator and methods therefore | |
AU1903799A (en) | Compositions and methods for modulating the activity of fibroblast growth factor | |
AU4317597A (en) | Hematopoietic stem cells and methods for generating such cells | |
AU2814897A (en) | Method of isolating regulators of t cell activation | |
AU3228197A (en) | Cell growth regulatory genes | |
AU8119294A (en) | Improved cell cultivation method and medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |